Primitive neuroectodermal tumor: Difference between revisions

Jump to navigation Jump to search
Maria Villarreal (talk | contribs)
No edit summary
Maria Villarreal (talk | contribs)
Line 7: Line 7:
==Overview==
==Overview==


'''Primitive neuroectodermal tumor''' (also known as "PNET") is a rare type of malignant [[neural crest]] tumor. Primitive neuroectodermal tumor arises from  the [[neuroectoderm]], which is normally involved in the development of the nervous system. Primitive neuroectodermal tumor was first discovered by James Ewing, an American pathologist, in 1921.<ref name="wiki>James Ewing. https://en.wikipedia.org/wiki/James_Ewing_(pathologist) Accessed on May 20, 2016 </ref>  Primitive neuroectodermal tumors are more commonly seen among children and young adults . The median age at diagnosis is 25 years of age. Prognosis is generally poor, and the 5-survival rate of patients with primitive neuroectodermal tumor is approximately 53%.<ref name="PNET"> PNET. Wikipedia. https://en.wikipedia.org/wiki/Primitive_neuroectodermal_tumor Acceded on May 23, 2016</ref><ref name="PNET"> PNET. Wikipedia. https://en.wikipedia.org/wiki/Primitive_neuroectodermal_tumor Acceded on May 23, 2016</ref>  
'''Primitive neuroectodermal tumor''' (also known as "PNET") is a rare type of malignant [[neural crest]] tumor. Primitive neuroectodermal tumor arises from  the [[neuroectoderm]], which is normally involved in the development of the nervous system. Primitive neuroectodermal tumor was first discovered by James Ewing, an American pathologist, in 1921.<ref name="wiki>James Ewing. https://en.wikipedia.org/wiki/James_Ewing_(pathologist) Accessed on May 20, 2016 </ref>  Primitive neuroectodermal tumors are more commonly seen among children and young adults . The median age at diagnosis is 25 years of age. Prognosis is generally poor, and the 5-survival rate of patients with primitive neuroectodermal tumor is approximately 53%.<ref name="PNET"> PNET. Wikipedia. https://en.wikipedia.org/wiki/Primitive_neuroectodermal_tumor Acceded on May 23, 2016</ref>


==Historical Perspective==
==Historical Perspective==

Revision as of 15:45, 23 May 2016

WikiDoc Resources for Primitive neuroectodermal tumor

Articles

Most recent articles on Primitive neuroectodermal tumor

Most cited articles on Primitive neuroectodermal tumor

Review articles on Primitive neuroectodermal tumor

Articles on Primitive neuroectodermal tumor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Primitive neuroectodermal tumor

Images of Primitive neuroectodermal tumor

Photos of Primitive neuroectodermal tumor

Podcasts & MP3s on Primitive neuroectodermal tumor

Videos on Primitive neuroectodermal tumor

Evidence Based Medicine

Cochrane Collaboration on Primitive neuroectodermal tumor

Bandolier on Primitive neuroectodermal tumor

TRIP on Primitive neuroectodermal tumor

Clinical Trials

Ongoing Trials on Primitive neuroectodermal tumor at Clinical Trials.gov

Trial results on Primitive neuroectodermal tumor

Clinical Trials on Primitive neuroectodermal tumor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Primitive neuroectodermal tumor

NICE Guidance on Primitive neuroectodermal tumor

NHS PRODIGY Guidance

FDA on Primitive neuroectodermal tumor

CDC on Primitive neuroectodermal tumor

Books

Books on Primitive neuroectodermal tumor

News

Primitive neuroectodermal tumor in the news

Be alerted to news on Primitive neuroectodermal tumor

News trends on Primitive neuroectodermal tumor

Commentary

Blogs on Primitive neuroectodermal tumor

Definitions

Definitions of Primitive neuroectodermal tumor

Patient Resources / Community

Patient resources on Primitive neuroectodermal tumor

Discussion groups on Primitive neuroectodermal tumor

Patient Handouts on Primitive neuroectodermal tumor

Directions to Hospitals Treating Primitive neuroectodermal tumor

Risk calculators and risk factors for Primitive neuroectodermal tumor

Healthcare Provider Resources

Symptoms of Primitive neuroectodermal tumor

Causes & Risk Factors for Primitive neuroectodermal tumor

Diagnostic studies for Primitive neuroectodermal tumor

Treatment of Primitive neuroectodermal tumor

Continuing Medical Education (CME)

CME Programs on Primitive neuroectodermal tumor

International

Primitive neuroectodermal tumor en Espanol

Primitive neuroectodermal tumor en Francais

Business

Primitive neuroectodermal tumor in the Marketplace

Patents on Primitive neuroectodermal tumor

Experimental / Informatics

List of terms related to Primitive neuroectodermal tumor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Primitive neuroectodermal tumors; PNET; CNS PNET; Askin tumor; Peripheral neuroepithelioma; Ependymoblastoma

Overview

Primitive neuroectodermal tumor (also known as "PNET") is a rare type of malignant neural crest tumor. Primitive neuroectodermal tumor arises from the neuroectoderm, which is normally involved in the development of the nervous system. Primitive neuroectodermal tumor was first discovered by James Ewing, an American pathologist, in 1921.[1] Primitive neuroectodermal tumors are more commonly seen among children and young adults . The median age at diagnosis is 25 years of age. Prognosis is generally poor, and the 5-survival rate of patients with primitive neuroectodermal tumor is approximately 53%.[2]

Historical Perspective

  • Primitive neuroectodermal tumor was first discovered by James Ewing, an American pathologist, in 1921.[1]

Classification

  • Primitive neuroectodermal tumor may be classified according to World Health Organization into 3 subtypes:[2]
  • Central primitive neuroectodermal tumors (PNETs)
  • Neuroblastomas
  • Peripheral primitive neuroectodermal tumors (pPNETs)

Pathophysiology

  • Primitive neuroectodermal tumor is composed of primitive undifferentiated neuroepithelial cells.[2]
  • Primitive neuroectodermal tumors are intracranial and usually located in the cerebral hemisphere.
  • The EWS-like gene has been associated with the development of primitive neuroectodermal tumor.
  • On gross pathology, characteristic findings of primitive neuroectodermal tumor, include:
  • Cystic components
  • On microscopic histopathological analysis, characteristic findings of primitive neuroectodermal tumor, include:[2]
  • Small blue cell tumor
  • Round hyperchromatic cells
  • Abundant mitotic figures
  • Homer Wright rosettes
  • Fibrosis

Causes

  • There are no established causes for primitive neuroectodermal tumor.

Differentiating Primitive Neuroectodermal Tumor from Other Diseases

  • Primitive neuroectodermal tumor must be differentiated from other diseases that cause seizures, or increase on intracranial pressure, such as:[2]
  • Astrocytoma
  • Ependymoma
  • Oligodendroglioma
  • Intracranial teratoma

Epidemiology and Demographics

  • The prevalence of primitive neuroectodermal tumor remains unknown.
  • Primitive neuroectodermal tumor account for 4-17% of all soft tissue paediatric tumors.[2]

Age

  • The median age at diagnosis is 25 years old.
  • Primitive neuroectodermal tumor is more commonly observed among children and young adults.

Gender

  • Primitive neuroectodermal tumor affects men and women equally.

Race

  • There is no racial predilection for primitive neuroectodermal tumor.

Risk Factors

  • Common risk factors in the development of primitive neuroectodermal tumor, include:

Natural History, Complications and Prognosis

  • The majority of patients with primitive neuroectodermal tumor remain asymptomatic for years.
  • Early clinical features are often unspecific.
  • If left untreated, patients with primitive neuroectodermal tumor may progress to develop
  • Common complications of primitive neuroectodermal tumor, include:
  • Increased intracranial pressure
  • Cranial nerve palsy
  • Seizures
  • Prognosis is generally poor, and the 5-survival rate of patients with primitive neuroectodermal tumor is approximately 53%.

Diagnosis

Symptoms

  • Clinical presentation of primitive neuroectodermal tumors is often non-specific.
  • Symptoms of primitive neuroectodermal tumor may include the following:
  • Obtain medical history, on the following syndromes:
  • Gorlin-Goltz syndrome
  • Turcot syndrome

Physical Examination

  • Patients with primitive neuroectodermal tumor usually are
  • Physical examination may be remarkable for:

Laboratory Findings

  • There are no specific laboratory findings associated with primitive neuroectodermal tumor.

Imaging Findings

  • MRI is the imaging modality of choice for primitive neuroectodermal tumor.
  • On CT, findings of primitive neuroectodermal tumor, include:
  • Often seen as a large irregular mass
  • Typically iso to hyper-attenuating on non contrast imaging
  • Cystic components are common (65%)
  • Calcification can be common (70% )
  • Shows heterogenous contrast enhancement
  • On MRI, findings of primitive neuroectodermal tumor, include:
  • T1: highly variable and can be hypointense to isointense
  • T2: generally high signal solid components
  • Cystic components are common
  • Low signal portions due to calcific components
  • T1 C+ (Gd): shows markedly heterogenous enhancement and leptomeningeal seeding is common
  • DWI: often shows restricted diffusion
  • MR spectroscopy: elevated choline, decreased NAA, elevated taurine (Tau) peak (relatively specific for PNET).

Treatment

Medical Therapy

  • There is no treatment for primitive neuroectodermal tumor; the mainstay of therapy is supportive care.

Surgery

  • Surgery is the mainstay of therapy for primitive neuroectodermal tumor.

Prevention

  • There are no primary preventive measures available for primitive neuroectodermal tumor.

References

  1. 1.0 1.1 James Ewing. https://en.wikipedia.org/wiki/James_Ewing_(pathologist) Accessed on May 20, 2016
  2. 2.0 2.1 2.2 2.3 2.4 2.5 PNET. Wikipedia. https://en.wikipedia.org/wiki/Primitive_neuroectodermal_tumor Acceded on May 23, 2016